Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
McKinsey
Colorcon
Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Medtronic
Mallinckrodt

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021545

« Back to Dashboard

NDA 021545 describes PATADAY, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PATADAY profile page.

The generic ingredient in PATADAY is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 021545
Tradename:PATADAY
Applicant:Novartis Pharms Corp
Ingredient:olopatadine hydrochloride
Patents:2
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021545
Suppliers and Packaging for NDA: 021545
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PATADAY olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545 NDA Alcon Laboratories, Inc. 0065-0272 N 0065-0272-25
PATADAY olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545 NDA Alcon Laboratories, Inc. 0065-0272 N 0065-0272-11

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.2% BASE
Approval Date:Dec 22, 2004TE:ATRLD:Yes
Patent:➤ Sign UpPatent Expiration:May 12, 2024Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Dec 19, 2022Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021545

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp PATADAY olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545-001 Dec 22, 2004 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp PATADAY olopatadine hydrochloride SOLUTION/DROPS;OPHTHALMIC 021545-001 Dec 22, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Fuji
Chinese Patent Office
UBS
Julphar
QuintilesIMS
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.